The recent pharmaceutical patent landscape for Alzheimer's disease: an interview with Sang Min Lim

Pharm Pat Anal. 2019 Nov;8(6):215-216. doi: 10.4155/ppa-2019-0022. Epub 2019 Nov 12.

Author

Sang Min Lim^{1

2}

Affiliations

¹ Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology, Seoul 02792, Republic of Korea.
² Division of Bio-Medical Science & Technology, KIST School, Korea University of Science & Technology, Seoul 02792, Republic of Korea.

PMID: 31713460
DOI: 10.4155/ppa-2019-0022

No abstract available

Keywords: aggregation; alzheimer’s disease; patent; post-translational modification; tau.

Publication types

Interview

MeSH terms

Alzheimer Disease / drug therapy*
Humans
Neuroprotective Agents / therapeutic use
Patents as Topic*
tau Proteins*

Substances

Neuroprotective Agents
tau Proteins